EPISODE · Jun 1, 2025 · 14 MIN
In conversation with... Changsong Qi
from Listen to The Lancet · host The Lancet
Changsong Qi joins Chloe Wilson and Ben Abbott of The Lancet to discuss their recently published phase 2 randomised controlled trial investigating Claudin-18 isoform 2-specific CAR T-cell therapy for previously treated advanced gastric or gastro-oesophageal junction cancer.
Embed this episode
NOW PLAYING
In conversation with... Changsong Qi
0:00
14:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet?
This episode is 14 minutes long.
When was this Listen to The Lancet episode published?
This episode was published on June 1, 2025.
Can I download this Listen to The Lancet episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!